0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Tuberculosis
 21-40 of 329 Articles
JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2013;310(22):2390. doi:10.1001/jama.2013.283220.

JAMA | 
Global Health | 
M. J. Friedrich
JAMA. 2013;310(19):2030. doi:10.1001/jama.2013.282527.

JAMA Ophthalmology | 
Case Report/Case Series | 
Mary Joseph, MS; Teena M. Mendonca, MBBS; Usha Vasu, MS, DNB; et al.
JAMA Ophthalmol. 2013;131(11):1463-1467. doi:10.1001/jamaophthalmol.2013.4840.

JAMA | 
Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2013;310(12):1217. doi:10.1001/jama.2013.277876.

JAMA Dermatology | 
Original Investigation |  FREE
Wonder P. Drake, MD; Kyra Oswald-Richter, PhD; Bradley W. Richmond, MD; et al.
JAMA Dermatol. 2013;149(9):1040-1049. doi:10.1001/jamadermatol.2013.4646.

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2013;310(2):135. doi:10.1001/jama.2013.7734.

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2013;309(22):2319. doi:10.1001/jama.2013.6388.

JAMA Ophthalmology | 
Clinical Sciences |  FREE
Sarju S. Patel, MD, MPH, MSc; Nehali V. Saraiya, MD; Howard H. Tessler, MD; et al.
JAMA Ophthalmol. 2013;131(6):752-758. doi:10.1001/jamaophthalmol.2013.71.

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2013;309(17):1766-1767. doi:10.1001/jama.2013.4319.

JAMA Pediatrics | 
Special Feature |  FREE
JAMA Pediatr. 2013;167(5):484. doi:10.1001/jamapediatrics.2013.7b.

JAMA | 
Viewpoint | 
Jerry Avorn, MD
JAMA. 2013;309(13):1349-1350. doi:10.1001/jama.2013.623.

JAMA | 
Medical News and Perspectives | 
Anita Slomski
JAMA. 2013;309(11):1097-1098. doi:10.1001/jama.2013.1802.

JAMA | 
Lab Reports | 
Tracy Hampton, PhD
JAMA. 2013;309(9):865. doi:10.1001/jama.2013.1314.

JAMA | 
JAMA Patient Page |  FREE
Ann R. Punnoose, MD; Cassio Lynm, MA; Robert M. Golub, MD
JAMA. 2013;309(9):938. doi:10.1001/2012.jama.10804.
Includes: Supplemental Content

JAMA | 
From the Centers for Disease Control and Prevention | 
JAMA. 2013;309(9):866-868. doi:10.1001/jama.2013.691.

JAMA | 
From the Centers for Disease Control and Prevention | 
JAMA. 2013;309(7):653. doi:10.1001/jama.2013.223.

JAMA | 
Medical News and Perspectives | 
Rebecca Voelker, MSJ
JAMA. 2013;309(5):430. doi:10.1001/jama.2013.94.

JAMA Otolaryngology–Head & Neck Surgery | 
Clinical Problem Solving: Radiology | 
Artemis Christoforidou, MD; Athanasios Kyrgidis, MD; Konstantinos Markou, MD, PhD; et al.
JAMA Otolaryngol Head Neck Surg. 2013;139(2):187. doi:10.1001/jamaoto.2013.1275a.

JAMA Otolaryngology–Head & Neck Surgery | 
Clinical Problem Solving: Radiology | 
JAMA Otolaryngol Head Neck Surg. 2013;139(2):188. doi:10.1001/jamaoto.2013.1275b.

JAMA | 
Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2012;308(19):1959-1960. doi:10.1001/jama.2012.14752.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Global Health  | 
Study Evaluates Shortened TB Drug Regimen
M.J. Friedrich
JAMA Internal Medicine
Teachable Moment  | 
The Diagnostic Cascade of Incidental Findings:  A Teachable Moment
Linh T. Nguyen, BS; Christopher T. Sullivan, BA; Anil N. Makam, MD, MAS
JAMA Pediatrics
Editorial  | 
Twelve-Dose Drug Regimen Now Also an Option for Preventing Tuberculosis in Children and Adolescents
Ben J. Marais, PhD
JAMA Pediatrics
Original Investigation  | 
Treatment for Preventing Tuberculosis in Children and Adolescents:  A Randomized Clinical Trial of a 3-Month, 12-Dose Regimen of a Combination of Rifapentine and Isoniazid
M. Elsa Villarino, MD, MPH; Nigel A. Scott, MS; Stephen E. Weis, DO; et al.